Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Colloid Interface Sci ; 599: 227-244, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33945970

ABSTRACT

The current study provides a novel insight into the role of synergism of the changes in Mg2+/ Al3+ in the best catalytic activity of indol-3-yl derivatives. A series of Co-Mg-Al layered triple hydroxides (LTHs) catalysts were produced by altering the Al3+/Mg2+ ratio with respect to Co2+. The physicochemical properties of LTHs were well characterized by ICP-AES, XRD, FTIR, FE-SEM, BET, Zeta-sizer, and VSM. The results show that the sample CMA4 (Co2+:Mg2+:Al3+ 2:4:4) is an exception to the physicochemical characteristics of the produced Co-Mg-Al LTHs, which is due to the synergism between the changes in Mg2+ and Al3+. To the best of our knowledge, this is the first study to report the synthesis of indol-3-yl derivatives from indole-3-carbaldehyde using Co-Mg-Al LTHs as highly efficient heterogeneous catalysts, which is an extremely appealing path. The selectivity of the synthesis was studied by condensing various nucleophiles through the one-pot method that established superior reactivity under mild conditions. Notably, the results show that the Co-Mg-Al LTHs system exhibited an extraordinarily catalytic activity, with the highest yield (98%) being obtained under the following optimal conditions: the concentration of Co-Mg-Al LTHs = 5 mol%, 30 min., water/ethanol as solvent. Furthermore, the reusable studies exhibited that the catalysts were found to be stable and reusable for up to six cycles without substantial loss of catalytic activity. Finally, a plausible reaction mechanism of the Co-Mg-Al LTHs system for indol-3-yl derivatives was put forward according to our comprehensive analysis. Our work illuminates a cheap and flexible strategy for the synthesis of indol-3-yl derivatives using Co-Mg-Al LTHs.

2.
Mol Divers ; 25(2): 673-686, 2021 May.
Article in English | MEDLINE | ID: mdl-32067133

ABSTRACT

Nicotinic acid hydrazide was incorporated into new 4,5-dihydro-5-hydroxy-3,5-diphenylpyrazol-1-yl derivatives. Compounds 6a-h were synthesized, and their antihyperlipidemic activity was evaluated in high cholesterol diet-fed rat model. Compounds 6e, 6f were found to decrease the levels of serum total cholesterol by 14-19% compared to control group. Total triglycerides were also reduced by 24-28% and LDL cholesterol by 16%. As expected from parent niacin, compounds 6e and 6f caused an elevation of HDL cholesterol by 33-41%. Docking study supported the ability of designed compounds to block NPC1L1 active site in a manner similar to that observed with ezetimibe.


Subject(s)
Hydrazines/therapeutic use , Hyperlipidemias/drug therapy , Hypolipidemic Agents/therapeutic use , Nicotinic Acids/therapeutic use , Pyrazoles/therapeutic use , Animals , Cholesterol/blood , Drug Design , Hydrazines/chemistry , Hyperlipidemias/blood , Hypolipidemic Agents/chemistry , Male , Membrane Transport Proteins/chemistry , Molecular Docking Simulation , Nicotinic Acids/chemistry , Pyrazoles/chemistry , Rats, Wistar , Triglycerides/blood
3.
ACS Omega ; 5(11): 6194-6198, 2020 Mar 24.
Article in English | MEDLINE | ID: mdl-32226904

ABSTRACT

This study describes the solvent and catalyst-free Ugi reaction by way of twin screw extrusion (TSE). Multicomponent chemical synthesis can be converted into a single process without repeated use of solvents through TSE. High synthetic yields are achieved in short reaction times and produced in solvent-free conditions, which lead to a more environmentally friendly process.

SELECTION OF CITATIONS
SEARCH DETAIL
...